Michael Sweeney has become a general partner of venture capital firm InterWest Partners of Menlo Park, Calif. In his new position, he will help the company identify investment opportunities in the life sciences. Sweeney joined InterWest in 1998 as an entrepreneur in residence and went on to become a venture partner in 2001. Among a host of other companies, he represents InterWest’s portfolio com-pany Fluidigm.
Â
Clive Brown has become head of bioinformatics at Little Chesterfield, UK-based Solexa. Prior to that, he was a bioinformatics consultant for Oxford GlycoSciences, where he was involved with the Protein Atlas of the Human Genome. He also consulted for a number of other biotechnology companies. Before that, Brown held various positions at the Wellcome Trust Center for Human Genetics in Oxford, GlaxoWellcome, and the Sanger Institute.